USCA RIA’s Zimmer Biomet ZBH Stock Holding History

USCA RIA’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$623K	Buy	3,992 +660	+20%	+$107K	0.04%	366
2021 Q1	$518K	Buy	+3,332	New	+$516K	0.03%	376

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

USCA RIA's ZBH Position: Q2 2021 in Review

USCA RIA increased its Zimmer Biomet (ZBH) stake by 20% in Q2 2021, buying an estimated $107K and bringing the position to 3,992 shares worth $623K. The position accounts for 0.04% of the portfolio, ranked #366.

USCA RIA first reported a position in ZBH in Q1 2021 and has held it in 2 quarters since. 1,018 funds tracked by Wall St. Rank hold ZBH as of Q2 2021.

USCA RIA held 3,992 shares of Zimmer Biomet worth $623K as of Q2 2021.
USCA RIA bought 660 Zimmer Biomet shares in Q2 2021, an estimated $107K.
Zimmer Biomet made up 0.04% of USCA RIA's portfolio in Q2 2021, its #366 holding.
USCA RIA first reported a position in Zimmer Biomet in Q1 2021 and has held it in 2 quarters since.
1,018 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2021.

Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.